High Tower Advisors, LLC Rocket Pharmaceuticals, Inc. Transaction History

High Tower Advisors, LLC

$71.6 Billion
Q4 2024

A detailed history of High Tower Advisors, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 17,748 shares of RCKT stock, worth $136,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,748

Previous 18,821 5.7%

Holding current value

$136,482

Previous $347,000 35.73%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$11.35 - $18.82 $12,178 - $20,193	-1,073 Reduced 5.7%	17,748 $223,000
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $97,785 - $143,789	-5,556 Reduced 22.79%	18,821 $347,000
Q2 2024 Aug 13, 2024	BUY	$20.66 - $26.72 $3,408 - $4,408	165 Added 0.68%	24,377 $524,000
Q1 2024 May 06, 2024	SELL	$26.16 - $30.74 $91,664 - $107,712	-3,504 Reduced 12.64%	24,212 $652,000
Q4 2023 Feb 12, 2024	SELL	$16.78 - $31.94 $16,780 - $31,940	-1,000 Reduced 3.48%	27,716 $830,000
Q3 2023 Nov 08, 2023	SELL	$15.07 - $24.05 $24,307 - $38,792	-1,613 Reduced 5.32%	28,716 $588,000
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $1.95 Million - $2.77 Million	-117,400 Reduced 79.47%	30,329 $602,000
Q1 2023 May 11, 2023	BUY	$15.79 - $22.6 $871,213 - $1.25 Million	55,175 Added 59.61%	147,729 $2.53 Million
Q4 2022 Feb 08, 2023	BUY	$15.5 - $22.76 $1.01 Million - $1.48 Million	65,107 Added 237.21%	92,554 $1.81 Million
Q3 2022 Nov 09, 2022	SELL	$12.37 - $18.41 $32,817 - $48,841	-2,653 Reduced 8.81%	27,447 $439,000
Q2 2022 Aug 10, 2022	BUY	$7.96 - $16.64 $72,436 - $151,424	9,100 Added 43.33%	30,100 $416,000
Q1 2022 May 12, 2022	BUY	$13.16 - $23.68 $64,207 - $115,534	4,879 Added 30.26%	21,000 $336,000
Q4 2021 Feb 10, 2022	BUY	$21.52 - $36.02 $16,376 - $27,411	761 Added 4.95%	16,121 $351,000
Q3 2021 Nov 12, 2021	SELL	$27.42 - $48.97 $21,936 - $39,176	-800 Reduced 4.95%	15,360 $460,000
Q2 2021 Aug 06, 2021	SELL	$39.41 - $47.25 $31,133 - $37,327	-790 Reduced 4.66%	16,160 $716,000
Q1 2021 May 10, 2021	SELL	$43.34 - $65.91 $55,605 - $84,562	-1,283 Reduced 7.04%	16,950 $750,000
Q4 2020 Feb 10, 2021	SELL	$23.3 - $59.57 $104,081 - $266,099	-4,467 Reduced 19.68%	18,233 $1 Million
Q3 2020 Nov 13, 2020	BUY	$20.5 - $28.59 $16,400 - $22,872	800 Added 3.65%	22,700 $518,000
Q2 2020 Aug 10, 2020	SELL	$13.32 - $22.61 $47,286 - $80,265	-3,550 Reduced 13.95%	21,900 $458,000
Q1 2020 May 21, 2020	BUY	$9.71 - $25.11 $12,137 - $31,387	1,250 Added 5.17%	25,450 $356,000
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $267,894 - $586,366	24,200 New	24,200 $552,000
Q3 2019 Nov 12, 2019	SELL	$10.85 - $14.78 $108,500 - $147,800	-10,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.45 - $19.01 $134,500 - $190,100	10,000 New	10,000 $176,000
Q3 2018 Nov 09, 2018	SELL	$18.5 - $25.49 $394,864 - $544,058	-21,344 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$14.58 - $23.0 $311,195 - $490,912	21,344 New	21,344 $422,000

Others Institutions Holding RCKT

# of Institutions

243

Shares Held

94.3M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $582M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Rocket Pharmaceuticals, Inc. Transaction History